Safety summaries

Adverse events by compound and indication

Curated summaries of source-backed named adverse-event rows from Blossom's clinical research database. Each page keeps coverage, limitations, and paper-level evidence visible so safety patterns stay tied to their sources.

Report pages
6
Source papers
96
Named AE rows
1014

Published safety summaries

These are generated from normalized named adverse-event rows and stored as editable Sanity reports. Residual papers are disclosed inside each page rather than treated as evidence of event absence.

Open first report

Esketamine for Depressive Disorders

Esketamine for Depressive Disorders: adverse events

Esketamine safety reports for Depressive Disorders most often include dizziness, headache, nausea, paresthesia among the source-backed named adverse events currently normalized in Blossom.

Papers with named AEs
8
Named AE rows
136

Common named events

dizziness 12.3%headache 17.2%nausea 28.1%paresthesia 6.93%
dizziness, headache, nausea

Ketamine for Depressive Disorders

Ketamine for Depressive Disorders: adverse events

Ketamine safety reports for Depressive Disorders most often include dizziness, headache, nausea, paresthesia among the source-backed named adverse events currently normalized in Blossom.

Papers with named AEs
26
Named AE rows
278

Common named events

dizziness 11.7%headache 15.6%nausea 22.3%paresthesia 6.93%
dizziness, headache, nausea

MDMA for PTSD

MDMA for PTSD: adverse events

MDMA safety reports for PTSD most often include headache, insomnia, anxiety, fatigue among the source-backed named adverse events currently normalized in Blossom.

Papers with named AEs
11
Named AE rows
176

Common named events

headache 65.2%insomnia 40.8%anxiety 32%fatigue 30.9%
headache, insomnia, anxiety

Psilocybin for Anxiety Disorders

Psilocybin for Anxiety Disorders: adverse events

Psilocybin safety reports for Anxiety Disorders most often include headache, nausea, anxiety, fatigue among the source-backed named adverse events currently normalized in Blossom.

Papers with named AEs
17
Named AE rows
80

Common named events

headache 41.5%nausea 23.8%anxiety 12.9%fatigue 9.15%
headache, nausea, anxiety

Psilocybin for Depressive Disorders

Psilocybin for Depressive Disorders: adverse events

Psilocybin safety reports for Depressive Disorders most often include headache, nausea, anxiety, fatigue among the source-backed named adverse events currently normalized in Blossom.

Papers with named AEs
22
Named AE rows
188

Common named events

headache 23.5%nausea 13.5%anxiety 7.77%fatigue 7.38%
headache, nausea, anxiety

Psilocybin for Substance Use Disorders (SUD)

Psilocybin for Substance Use Disorders (SUD): adverse events

Psilocybin safety reports for Substance Use Disorders (SUD) most often include headache, nausea, anxiety, insomnia among the source-backed named adverse events currently normalized in Blossom.

Papers with named AEs
12
Named AE rows
156

Common named events

headache 30.7%nausea 17.6%anxiety 12.8%insomnia 5.49%
headache, nausea, anxiety

How to interpret these pages

The summaries aggregate named adverse-event rows that are already normalized in Blossom. They are meant for evidence navigation and source review, not formal pharmacovigilance or direct cross-trial safety comparisons. Use the paper links and limitations on each report page when interpreting counts or rates.